These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2663036)

  • 21. Bone mineral and aluminum concentrations in patients undergoing CAPD.
    Giangrande A; Costanini S; Ballanti P; Castiglioni A; Caligara F; Pisoni B; Giordano R; Vernillo I; Berni S; Bonucci E
    Adv Perit Dial; 1992; 8():351-5. PubMed ID: 1361821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of bone remodeling: impact of novel therapies.
    Hercz G
    Semin Dial; 2001; 14(1):55-60. PubMed ID: 11208041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal bone disease.
    Cundy TF; Kanis JA
    Br J Hosp Med; 1985 Jan; 33(1):35-40. PubMed ID: 3882177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of renal osteodystrophy in patients treated by continuous ambulatory peritoneal dialysis.
    El Shahat Y; Jacobs C; Issad B; Rottembourg J; Legrain M
    Adv Exp Med Biol; 1982; 151():429-40. PubMed ID: 7180661
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.
    Salusky IB; Coburn JW; Brill J; Foley J; Slatopolsky E; Fine RN; Goodman WG
    Kidney Int; 1988 May; 33(5):975-82. PubMed ID: 3392886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in calcium kinetic pattern between CAPD and HD patients.
    Kurz P; Tsobanelis T; Roth P; Werner E; Ewald U; Grützmacher P; Schoeppe W; Vlachojannis J
    Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vitamin D metabolism and chronic kidney disease].
    Honda H; Sanada D; Akizawa T
    Clin Calcium; 2006 Jul; 16(7):1143-46. PubMed ID: 16816474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous ambulatory peritoneal dialysis and vitamin D.
    Rapoport J; Shany S; Chaimovitz C
    Nephron; 1988; 48(1):1-3. PubMed ID: 3277074
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].
    Hamada Y; Fukagawa M
    Clin Calcium; 2009 Apr; 19(4):486-92. PubMed ID: 19329826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal osteodystrophy and metastatic calcification in long-term continuous ambulatory peritoneal dialysis.
    Cassidy MJ; Owen JP; Ellis HA; Dewar J; Robinson CJ; Wilkinson R; Ward MK; Kerr DN
    Q J Med; 1985 Jan; 54(213):29-48. PubMed ID: 3975345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Review on internal medicine, 1984. Electrolyte disturbance. III-3. Renal osteodystrophy].
    Ogura Y
    Nihon Naika Gakkai Zasshi; 1985 Jun; 74(6):726-30. PubMed ID: 4045286
    [No Abstract]   [Full Text] [Related]  

  • 33. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL; Fournier AE; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(38):3533-7. PubMed ID: 341079
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal bone disease in peritoneal dialysis.
    Cunningham J
    Perit Dial Int; 1999; 19 Suppl 2():S397-401. PubMed ID: 10406553
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hormonal changes in and therapy of renal osteodystrophy].
    Löcsey L; Kakuk G; Szabó T; Wórum I; Nagy Z; Leövey A
    Orv Hetil; 1980 Aug; 121(35):2121-7. PubMed ID: 7465173
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bone and joint complications in patients treated with continuous ambulatory peritoneal dialysis (CAPD) for more than 3 years].
    Dratwa M; Wens R; Collart F; Tielemans C
    Nephrologie; 1989; 10 Suppl():56-61. PubMed ID: 2812191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renal osteodystrophy. I. Recent pathophysiological acquisitions (author's transl)].
    Sebert JL; Fournier A; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(37):3419-24. PubMed ID: 341075
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of renal osteodystrophy in peritoneal dialysis.
    Weinreich T
    Kidney Int; 1998 Dec; 54(6):2226-33. PubMed ID: 9853289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
    Bordier PJ; Marie PJ; Arnaud CD
    Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous ambulatory peritoneal dialysis and bone.
    Delmez JA; Fallon MD; Bergfeld MA; Gearing BK; Dougan CS; Teitelbaum SL
    Kidney Int; 1986 Sep; 30(3):379-84. PubMed ID: 3784281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.